Therefore, further investigation into the role of DUB proteins in relation to CIP2A could provide deeper insights into the function of CIP2A in the pathogenesis of lung cancer and identifying DUB could significantly contribute to the development of CIP2A inhibitors as a therapeutic target in cancer. This evidence concerns the gene CIP2A and lung cancer.